InvestorsHub Logo
Followers 105
Posts 16324
Boards Moderated 0
Alias Born 06/24/2014

Re: None

Wednesday, 04/10/2024 8:35:09 AM

Wednesday, April 10, 2024 8:35:09 AM

Post# of 277
ABVC BioPharma Executes a Global Licensing Term Sheet for Oncology/Hematology Products, Expecting Licensing Income of $55M and Royalties of up to $50M
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ABVC News